Table 2.
Characteristics | HR (95% CI) | |||
Crude* | P-value | Adjusted*† | P-value | |
Total participants (n=17 550) | ||||
Parkinson’s disease | 2.29 (2.13 to 2.45) | <0.001‡ | 2.09 (1.94 to 2.24) | <0.001‡ |
Control | 1.00 | 1.00 | ||
Age <70 years old, men (n=2115) | ||||
Parkinson’s disease | 3.04 (2.45 to 3.77) | <0.001‡ | 2.77 (2.23 to 3.45) | <0.001‡ |
Control | 1.00 | 1.00 | ||
Age <70 years old, women (n=3125) | ||||
Parkinson’s disease | 4.11 (3.24 to 5.21) | <0.001‡ | 3.32 (2.60 to 4.25) | <0.001‡ |
Control | 1.00 | 1.00 | ||
Age 70–79 years old, men (n=3280) | ||||
Parkinson’s disease | 2.27 (1.96 to 2.63) | <0.001‡ | 2.07 (1.78 to 2.41) | <0.001‡ |
Control | 1.00 | 1.00 | ||
Age 70–79 years old, women (n=5410) | ||||
Parkinson’s disease | 2.41 (2.10 to 2.78) | <0.001‡ | 2.22 (1.92 to 2.55) | <0.001‡ |
Control | 1.00 | 1.00 | ||
Age≥80 years old, men (n=1285) | ||||
Parkinson’s disease | 1.53 (1.25 to 1.88) | <0.001‡ | 1.47 (1.20 to 1.82) | <0.001‡ |
Control | 1.00 | 1.00 | ||
Age≥80 years old, women (n=2335) | ||||
Parkinson’s disease | 1.83 (1.55 to 2.17) | <0.001‡ | 1.73 (1.46 to 2.05) | <0.001‡ |
Control | 1.00 | 1.00 |
*Stratified model for age, sex, income and region of residence.
†Model adjusted for the Charlson Comorbidity Index.
‡Cox proportional hazard regression model; significance at p<0.05.